Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 163 participants.
Also called NCT07564726
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 163 participants
- Sponsor
- Celltrion Pharm, Inc.
- Registry
-
NCT07564726
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT07564726. Randomized; quadruple masking; primary purpose treatment. Start 2022-08-05 (actual); primary completion 2024-02-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Ezetimibe/Rosuvastatin and Amlodipine Patients With High Blood Pressure and High Cholesterol
- Condition
- Hypertension
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Ezetimibe/Rosuvastatin
- Intervention (Drug)
- Ezetimibe/Rosuvastatin Placebo
- Intervention (Drug)
- Amlodipine Placebo
- Lead sponsor
- Celltrion Pharm, Inc.
Record details
- Record id
cardio:ct-nct07564726- Content hash
faf9fa73d4241a938ae4b5e705f56680cb6dc6c16e2b90da8c502cf56fecfe0f